Welcome to our dedicated page for P3 Health Partners SEC filings (Ticker: PIIIW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
P3 Health Partners Inc. filings document the public-company reporting record for a population health management business and its Nasdaq-listed warrants exercisable for Class A common stock. Proxy statements cover annual meeting matters and corporate governance, while Form 8-K reports describe material agreements, amendments to debt instruments, unregistered equity securities, charter or bylaw matters and Nasdaq stockholders’ equity compliance topics.
The filing record also includes disclosures involving P3 Health Group, LLC and service arrangements under the company’s Care Enablement Model, including clinical, operational and data-driven support for primary care providers in Medicare Advantage networks.
P3 Health Partners reported that director Mark Thierer was granted 4,000 restricted stock units (RSUs) under the company’s 2021 Incentive Award Plan, with the award recorded on 08/06/2025. Each RSU represents the right to receive one share of Class A common stock and the RSUs vest in one year from the grant date, meaning the shares will be issued if the vesting conditions are met. The filing shows the RSUs were issued at no cash price and increased Thierer’s reported beneficial ownership to 437,121 shares, held directly. No derivative securities were reported in this filing.
P3 Health Partners Inc. director Gregory D. Wasson received a grant of 2,000 restricted stock units (RSUs) on 08/06/2025 reported on a Form 4. The RSUs were granted under the 2021 Incentive Award Plan and each RSU represents the right to receive one share of Class A common stock. The award carries a $0 price and vests one year from the grant date. Following the reported transaction, Mr. Wasson is shown as beneficially owning 218,561 shares directly. The filing was signed by an attorney-in-fact on 08/08/2025.
P3 Health Partners Inc. reported a director-level equity award: Jeffrey G. Park was granted 2,000 restricted stock units (RSUs) under the company's 2021 Incentive Award Plan. Each RSU represents a right to receive one share of Class A common stock and the RSUs vest one year from the grant date. The grant was recorded as an acquisition at a $0 price and the filing shows 218,561 shares beneficially owned by the reporting person following the award, held in a direct form of ownership. This filing documents a routine equity-based compensation event for a director, specifying award mechanics and post-grant holdings.
P3 Health Partners Inc. (PIII) Form 4 summary: Director Leisure Lawrence B. was granted 2,000 restricted stock units (RSUs) on 08/06/2025 under the P3 Health Partners 2021 Incentive Award Plan. Each RSU represents a right to receive one share of Class A common stock and the RSUs vest one year from the grant date. The grant was recorded at a $0 price. Following the reported transaction, the reporting person beneficially owned 218,561 Class A shares. The Form 4 lists the reporting person as a director and was signed by an attorney-in-fact on 08/08/2025.
P3 Health Partners Inc. Director Thomas Edmunds Price was granted 2,000 restricted stock units (RSUs) on 08/06/2025. Each RSU represents a right to receive one share of Class A common stock and the award vests one year from the grant date, meaning delivery of shares occurs only after vesting. The grant was made under the company’s 2021 Incentive Award Plan and shows an acquisition at no cash price.
After the grant, the filing reports 218,561 shares beneficially owned by the reporting person on a direct basis. This transaction is a typical equity-based compensation award to a director and does not reflect an immediate sale or transfer of issued shares.